INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 155 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q1 2017. The put-call ratio across all filers is 0.74 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $618,000 | +122.3% | 7,366 | +62.6% | 0.02% | +112.5% |
| Q1 2018 | $278,000 | -72.3% | 4,530 | -50.9% | 0.01% | -75.8% |
| Q4 2016 | $1,002,000 | -44.9% | 9,222 | -16.6% | 0.03% | -45.0% |
| Q3 2016 | $1,820,000 | +787.8% | 11,060 | +706.1% | 0.06% | +757.1% |
| Q4 2015 | $205,000 | -5.5% | 1,372 | +5.1% | 0.01% | -12.5% |
| Q3 2015 | $217,000 | -37.5% | 1,306 | -9.1% | 0.01% | -33.3% |
| Q2 2015 | $347,000 | -21.1% | 1,437 | -7.9% | 0.01% | -20.0% |
| Q1 2015 | $440,000 | – | 1,560 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WHITE SQUARE CAPITAL LLP | 65,500 | $7,117,000 | 11.05% |
| Ghost Tree Capital, LLC | 70,000 | $7,606,000 | 1.83% |
| Carmignac Gestion | 2,022,792 | $219,776,000 | 1.71% |
| Orbimed Advisors | 1,120,000 | $121,688,000 | 1.55% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 29,555 | $3,211,000 | 1.45% |
| Parametrica Management Ltd | 10,814 | $1,175,000 | 1.16% |
| BB BIOTECH AG | 255,719 | $27,784,000 | 1.03% |
| SECTORAL ASSET MANAGEMENT INC | 74,150 | $8,056,000 | 0.89% |
| ALTRINSIC GLOBAL ADVISORS LLC | 188,904 | $20,524,000 | 0.76% |
| FALCON POINT CAPITAL, LLC | 45,005 | $4,890,000 | 0.66% |